Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
08/22/1995 | US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma |
08/22/1995 | US5444080 Hypotensive agents |
08/22/1995 | US5444069 Imidazo-pyridine angiotensin II antagonists used to treat memory loss |
08/22/1995 | US5444065 Fused cycloalkylimidazopyridines as inducer of interferon α biosynthesis |
08/22/1995 | US5443962 Methods of identifying inhibitors of cdc25 phosphatase |
08/22/1995 | US5443842 Mixed with isopropyl myristate or palmitate and polyethoxy-lated, hydrogenated castor oils |
08/22/1995 | US5443839 Liposomes containing scutellaria extracts |
08/22/1995 | CA2030077C Azabicyclo amides and esters as 5-ht _receptor antagonists |
08/22/1995 | CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives |
08/17/1995 | WO1995021931A1 Nucleic acid-containing composition, its preparation and use |
08/17/1995 | WO1995021927A2 Targeting gene therapy |
08/17/1995 | WO1995021917A1 Mammalian cell cycle protein |
08/17/1995 | WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
08/17/1995 | WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021843A1 Azacyclic derivatives |
08/17/1995 | WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
08/17/1995 | WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021838A1 Pyridyl imidazole derivatives and processes for the preparation thereof |
08/17/1995 | WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | WO1995021817A1 Substituted spiro compounds for the treatment of inflammation |
08/17/1995 | WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/17/1995 | WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
08/17/1995 | WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors |
08/17/1995 | CA2183254A1 Mammalian cell cycle protein |
08/17/1995 | CA2182950A1 Substituted spiro compounds for the treatment of inflammation |
08/17/1995 | CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/17/1995 | CA2182494A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
08/17/1995 | CA2182118A1 Nucleic acid-containing composition, its preparation and use |
08/17/1995 | CA2160591A1 Protein having tpo activity |
08/17/1995 | CA2141506A1 Cosmetic or pharmaceutical compositions containing liposomes |
08/16/1995 | EP0667347A1 Beta-carboline thromboxane synthase inhibitors |
08/16/1995 | EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists |
08/16/1995 | EP0667342A1 Substituted Arylureas and their use as anti-atheriosclerotic compounds |
08/16/1995 | EP0667340A1 Isatine derivates, their preparation and their use as excitatory amino acid receptor antagonist |
08/16/1995 | EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor |
08/16/1995 | EP0667152A1 Oral use of calcium formate for the treatment of calcium deficiency in animals |
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors |
08/16/1995 | EP0666862A1 6-(substituted methylene) penems and intermediates |
08/16/1995 | EP0666858A1 5-arylindole derivatives and their use as serotonin (5-ht 1?) agonists |
08/16/1995 | EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
08/16/1995 | EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
08/16/1995 | EP0666847A1 Tryptamine analogs with 5-ht1d selectivity |
08/16/1995 | EP0666844A1 Inhibitors of farnesyl-protein transferase |
08/16/1995 | EP0666759A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
08/16/1995 | EP0666755A1 Inhibitiion of retrovirus infection |
08/16/1995 | EP0666744A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |
08/16/1995 | EP0666738A1 Inhibitors of farnesyl-protein transferase |
08/16/1995 | EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases |
08/16/1995 | CN1106982A Thiazole or imidazole derivatives as maillard reaction inhibitors |
08/16/1995 | CN1106813A 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity |
08/16/1995 | CN1106812A Tricyclic diazepine vasopressin antagonists |
08/16/1995 | CN1106811A Piperidines and piperazines |
08/16/1995 | CN1106806A Adhesion receptor antagonists |
08/16/1995 | CN1106805A Sulfonamide endothelin antagonists |
08/16/1995 | CN1106802A Tricyclic benzazepine vasopressin antagonists |
08/16/1995 | CN1106801A Isoquinolines |
08/16/1995 | CN1106701A Pharmaceutical composition |
08/16/1995 | CN1106666A Pharmaceutical use of 24-homo-vitamin-D-derivative |
08/15/1995 | US5442110 Connective tissue disorders |
08/15/1995 | US5442104 Inhibitors of kynureninase |
08/15/1995 | US5442101 Methylenebisphosphonic acid derivatives |
08/15/1995 | US5442008 Stabilized polymer film coated compounds and stabilized formulations in compressed from using same |
08/15/1995 | US5441976 Immunostimulants |
08/15/1995 | US5441975 Anticholesterol agent |
08/15/1995 | US5441965 Methods of inhibiting thrombin |
08/15/1995 | US5441964 Methods for inhibiting bone loss using substituted benzothiophene |
08/15/1995 | US5441959 Hypotensive agents; treating congestive heart failure and glaucoma,inhibiting restenosis |
08/15/1995 | US5441945 Heterocyclic iminobismethylenebisphosphonic acid derivatives |
08/15/1995 | US5441868 Production of recombinant erythropoietin |
08/15/1995 | CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
08/15/1995 | CA1336711C Lactam derivatives, their preparation and their use as hypotensive agents |
08/15/1995 | CA1336686C Method of inhibiting onset of or treating migraine headache using a thromboxane a- receptor antagonist |
08/15/1995 | CA1336684C Dsrna-based prevention of viral escape |
08/15/1995 | CA1336678C Prophylaxis and treatment of nervous system diseases with melanin |
08/10/1995 | WO1995021194A1 Superactive vip antagonists |
08/10/1995 | WO1995021187A1 Cyclic neurokinin a antagonists |
08/10/1995 | WO1995021186A1 Macrocyclic difluorostatone derivatives useful as antiviral agents |
08/10/1995 | WO1995021184A1 Substituted purines and oligonucleotide cross-linking |
08/10/1995 | WO1995021179A1 Endotoxin reduction or removal process |
08/10/1995 | WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
08/10/1995 | WO1995021173A1 Process for the preparation of a salt of clavulanic acid |
08/10/1995 | WO1995021167A1 Triazole derivatives |
08/10/1995 | WO1995021166A1 Triazole derivatives |
08/10/1995 | WO1995021165A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists |
08/10/1995 | WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | WO1995020950A1 Therapeutic guanidines |
08/10/1995 | WO1995017876A3 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
08/10/1995 | CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | CA2182302A1 Therapeutic guanidines |
08/10/1995 | CA2182197A1 Triazole derivatives |
08/10/1995 | CA2182196A1 Triazole derivatives |
08/09/1995 | EP0666252A1 Phenyl substituted alkyl carboxylic acid guanidines with perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing the same |
08/09/1995 | EP0666076A2 Water in oil emulsion containing retinol |
08/09/1995 | EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
08/09/1995 | EP0665843A1 Substituted quinuclidines as substance p antagonists |
08/09/1995 | EP0665842A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |